Session » Systemic Sclerosis & Related Disorders – Clinical Poster III

Date: Sunday, November 8, 2020

Time: 9:00AM-11:00AM

Meeting: ACR Convergence 2020

9:00AM-11:00AM: Abstract Number: 1388

A Systematic Assessment of Demographics, Clinical and Serological Features Associated with Colonic Hypomotility in Systemic Sclerosis

9:00AM-11:00AM: Abstract Number: 1391

Associations Between Autoantibodies in Systemic Sclerosis and Cancer in a National Registry

9:00AM-11:00AM: Abstract Number: 1382

Changes in Imaging Markers in Patients with Systemic Sclerosis-Associated Interstitial Lung Disease (SSc-ILD) Treated with Nintedanib: Sub-Study of the SENSCIS Trial

9:00AM-11:00AM: Abstract Number: 1397

Clinical and Demographic Features of Morphea Patients with Mucocutaneous Involvement: A Cross Sectional Study from the Morphea of Adults and Children Cohort

9:00AM-11:00AM: Abstract Number: 1389

Clinical Characteristics and Treatment Outcome of a Cohort of Patients with Joint and Fascial Involvement in the Context of Chronic Graft versus Host Disease

9:00AM-11:00AM: Abstract Number: 1386

Clinical Correlates and Relevance of the UCLA GIT 2.0 Instrument for Indication for Esophagogastroduodenoscopy and Endoscopic Esophagitis in Real-life Patients with Systemic Sclerosis

9:00AM-11:00AM: Abstract Number: 1379

Clinical Outcomes Among Participants with Diffuse Systemic Sclerosis Contracting COVID-19 During Clinical Studies of Lenabasum: A Case Series

9:00AM-11:00AM: Abstract Number: 1396

Digital Artery Volume Index (Davix©) Predicts Onset of Future Digital Ulcers in Patients with Systemic Sclerosis

9:00AM-11:00AM: Abstract Number: 1380

Digital Occlusive Arterial Disease on Laser Doppler Flowmetry Increases the Risk of Digital Ischemic Complications in Systemic Sclerosis: Results from a Single Center Referral Cohort (2001-2018)

9:00AM-11:00AM: Abstract Number: 1392

Long-Term Tolerability of Aminaphtone in Raynaud’s Phenomenon Secondary to Systemic Sclerosis

9:00AM-11:00AM: Abstract Number: 1390

Outcomes of Systemic Sclerosis Patients Who Were Primarily Admitted for Acute Myocardial Infarction from 2016 to 2017: Insights from the National Inpatient Sample

9:00AM-11:00AM: Abstract Number: 1394

Pathway to Systemic Sclerosis: Concerning Patients’ Experiences During the Diagnostic Process

9:00AM-11:00AM: Abstract Number: 1385

Physical Therapy in Patients with Systemic Sclerosis: The Perspective of Physical Therapists on Current Delivery and Educational Needs

9:00AM-11:00AM: Abstract Number: 1395

Poor Maternal and Fetal Outcome in Indian Women with Systemic Sclerosis: Interview-based Study at a Tertiary Center in India

9:00AM-11:00AM: Abstract Number: 1377

Raynaud’s Phenomenon and Systemic Sclerosis in Post-9/11 Deployed Veterans Receiving Care Veterans Health Administration Care

9:00AM-11:00AM: Abstract Number: 1381

Real-World Mono-, Double and Triple Combination Treatment Patterns with Macitentan in Patients with Pulmonary Arterial Hypertension Associated with Connective Tissue Disease (PAH-CTD): Evidence from the Combined OPUS/OrPHeUS Dataset

9:00AM-11:00AM: Abstract Number: 1387

Should Systemic Sclerosis Patients with Low Bicarbonate Have Replacement to Prevent Renal Dysfunction?

9:00AM-11:00AM: Abstract Number: 1393

Systemic Sclerosis: Subclinical Aterosclerosis and Morbimortality

9:00AM-11:00AM: Abstract Number: 1398

The Isolated Nucleolar Pattern ANA Antibody in a Systemic Sclerosis Patient Cohort

9:00AM-11:00AM: Abstract Number: 1383

Tocilizumab Shows Potential in Preserving Lung Function in Systemic Sclerosis with Positive anti-topoisomerase-1 (Scl-70): A Single Centre Cohort Study

9:00AM-11:00AM: Abstract Number: 1378

Understanding Diagnostic Pathways in Systemic Sclerosis and Systemic Sclerosis-Associated Interstitial Lung Disease (SSc-ILD)

9:00AM-11:00AM: Abstract Number: 1384

Usage, Needs and Preferences Regarding Physical Therapy in Patients with Systemic Sclerosis

« View all sessions from this meeting